Leptin: A novel therapeutic target in Alzheimer's disease?

33Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

It is well established that the hormone leptin circulates in the plasma in amounts proportional to body fat content and it regulates food intake and body weight via its actions in the hypothalamus. However, numerous studies have shown that leptin receptors are widely expressed throughout the CNS and evidence is growing that leptin plays a role in modulating a variety of neuronal processes. In particular, recent studies have highlighted a potential cognitive enhancing role for leptin as it regulates diverse aspects of hippocampal synaptic function that are thought to underlie learning and memory processes including glutamate receptor trafficking, dendritic morphology, and activity-dependent synaptic plasticity. Characterisation of the novel actions of leptin in limbic brain regions is providing valuable insights into leptins role in higher cognitive functions in health and disease. Copyright © 2012 Dayne Beccano-Kelly and Jenni Harvey.

Cite

CITATION STYLE

APA

Beccano-Kelly, D., & Harvey, J. (2012). Leptin: A novel therapeutic target in Alzheimer’s disease? International Journal of Alzheimer’s Disease. https://doi.org/10.1155/2012/594137

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free